Analysis of delays in diagnosis and treatment of breast cancer patients at a public hospital;Análise do atraso no diagnóstico e tratamento do câncer de mama em um hospital público

Revista da Associacao Medica Brasileira

Volumn 54, Issue 1, 2008, Pages 72-76

  Trufelli, Damila Cristina ^a,b   Miranda, Vanessa Da Costa ^a   Dos Santos, Maria Beatriz Brisola ^a   Fraile, Natália Moreno Perez ^a   Pecoroni, Priscilla Guedes ^a   Gonzaga, Suzana De França Ribeiro ^a   Riechelmann, Rachel ^a   Kaliks, Rafael ^a   Del Giglio, Auro ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Breast cancer; Delays; Diagnosis; Treatment

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; BIOPSY; BRAZIL; BREAST TUMOR; CANCER CENTER; CHI SQUARE DISTRIBUTION; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; PATHOLOGY; PATIENT REFERRAL; PUBLIC HOSPITAL; RADIOGRAPHY; RETROSPECTIVE STUDY; TIME;

ANALYSIS OF VARIANCE; BIOPSY; BRAZIL; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALS, PUBLIC; HUMANS; MAMMOGRAPHY; MIDDLE AGED; ONCOLOGY SERVICE, HOSPITAL; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 42149107682     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302008000100024     Document Type: Article

References (24)

1. Surveillance epidemiology and end results (SEER). National Cancer Institute. [cited 2007 mayo 22]. Disponível em: http://seer.cancer.gov.
2. Estimativas da incidência e mortalidade por câncer no Brasil. Ministério da Saúde: Instituto Nacional do Câncer. [citado 6 maio 2007]. Disponível em: http://www.inca.gov.br.
3. Câncer de mama. Ministério da Saúde: Instituto Nacional do Câncer. citado 6 maio 2007]. Disponível em: http://www.inca.gov.br.
4. Barros ACSD, Barbosa EM, Gebrim LH. Projeto diretrizes: diagnóstico e tratamento do câncer de mama. Sociedade Brasileira de Mastologia. [citado 6 maio 2007]. Disponível em: http://www. sbmastologia.com.br.
5. Trufelli DC, Bensi CG, Pane CEV, Ramos E, Otsuka FC, Tannous NG, et al. Onde está o atraso? Avaliação do tempo necessário para o diagnóstico e tratamento do câncer de mama nos serviços de oncologia da Faculdade de Medicina do ABC. Rev Bras Mastol. 2007;17(1):14-8.
6. Caplan LS, Edwards BK, Helzlsouer KJ, Shapiro S, Wesley MN. Reasons for delay in breast cancer diagnosis. Prev Med. 1996;25(2):218-24.
7. Coates AS. Breast cancer: delays, dilemmas, and delusions. Lancet 1999;353(9158):1112-3.
8. Nystrom L, Rutqvist LE, Wall L. Breast cancer screening with mammography: overview of the Swedish randomized trials. Lancet 1993;341(8851):973-8.
9. Ramirez AJ, Westcombe AM, Burgess CC. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127-31.
10. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer. 2002;94(8):2143-50.
11. Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer. 1975; 35(3):714-20.
12. Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M. Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol. 1994;33(4):345-51.
13. Tartter PI, Pace D, Frost M, Bernstein JL. Delay in diagnosis of breast cancer. Ann Surg. 1999;229(1):91-6.
14. Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98(8):238-9.
15. Gullatte MM, Phillips JM, Gibson LM. Factors associated with delays in screening of self-detected breast changes in African-American women. J Natl Black Nurses Assoc. 2006;17(1):45-50.
16. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(20):2244-52.
17. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119-26.
18. Montella M, Crispo A, D'Aiuto G, De Marco M, Bellis G, Fabbrocini G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10(1):53-9.
19. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995;345(8960):1265-70.
20. Richardson JBL, Bernstein C, Burciaga C, Danley R, Ross R. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer. 1992;65(6):922-6.
21. Montella M, Crispo A, Botti G, De Marco M, de Bellis G, Fabbrocini G, et al. An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Br Cancer Res Treat. 2001;66(3):209-15.
22. Cant PJ, Yu DSL. Impact of the '2 week wait' directive for suspected cancer on service provision in a symptomatic breast clinic. Br J Surg. 2000;87(8):1082-6.
23. Cold S, Düring M, Ewertz M, Knoop A, Møller S. Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer. 2006;94(6):938-9.
24. Shannon C, Ashley S, Smith IE. Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol. 2003;21(20):3792-7.